Complete Blood Count-Derived Biomarkers’ Association with Risk of PD-1 or PD-1/CTLA-4 Inhibitor-Induced Hypothyroidism in Patients with Solid Tumors

Background: A novel and highly effective strategy for tumor immunotherapy involves enhancing host immune responses against tumors through the blockade of checkpoint molecules. The most common toxicities associated with checkpoint blockade therapies include autoimmune damage to various organs. Purpos...

詳細記述

書誌詳細

出版年:	Immuno
主要な著者:	Ketevan Lomidze, Nino Kikodze, Marine Gordeladze, Nino Charkviani, Tinatin Chikovani
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2025-06-01
主題:	immune checkpoint inhibitors hypothyroidism CBC-derived biomarkers
オンライン･アクセス:	https://www.mdpi.com/2673-5601/5/2/21